| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 2065 |
| 1 | ASPIRIN | 1604 |
| 2 | ASPIRIN 325 MG | 1552 |
| 3 | ASPIRIN 81 MG | 1552 |
| 4 | APIXABAN | 1412 |
| 5 | WARFARIN | 1277 |
| 6 | DABIGATRAN ETEXILATE | 1205 |
| 7 | DABIGATRAN ETEXILATE MESYLATE | 1182 |
| 8 | CLOPIDOGREL | 943 |
| 9 | ALTEPLASE | 741 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TENECTEPLASE | 118 | 0.0737 |
| 1 | TIROFIBAN | 181 | 0.0622 |
| 2 | ALTEPLASE | 741 | 0.0493 |
| 3 | IDARUCIZUMAB | 67 | 0.0467 |
| 4 | BIVALIRUDIN | 25 | 0.0252 |
| 5 | CANGRELOR | 10 | 0.0248 |
| 6 | IBUPROFEN LYSINE | 14 | 0.0246 |
| 7 | LIFILEUCEL | 6 | 0.0211 |
| 8 | APIXABAN | 1412 | 0.0207 |
| 9 | PRASUGREL HYDROCHLORIDE | 173 | 0.0170 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 3458 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2077 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 1653 |
| 3 | Corticosteroid [EPC] | 1057 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 756 |
| 5 | Loop Diuretic [EPC] | 669 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 623 |
| 7 | Proton Pump Inhibitor [EPC] | 581 |
| 8 | Alkylating Drug [EPC] | 500 |
| 9 | Kinase Inhibitor [EPC] | 477 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 67 | 0.0467 |
| 1 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 2 | Factor Xa Inhibitor [EPC] | 3458 | 0.0125 |
| 3 | Lymphocyte Growth Factor [EPC] | 13 | 0.0103 |
| 4 | Anti-coagulant [EPC] | 37 | 0.0099 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 41 | 0.0070 |
| 6 | Provitamin D2 Compound [EPC] | 197 | 0.0066 |
| 7 | Human Antihemophilic Factor [EPC] | 1 | 0.0065 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 756 | 0.0063 |
| 9 | CD33-directed Immunoconjugate [EPC] | 20 | 0.0055 |